| Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed … AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, ... JAMA oncology 6 (4), 495-503, 2020 | 397 | 2020 |
| Characterization of serial hyperpolarized 13C metabolic imaging in patients with glioma AW Autry, JW Gordon, HY Chen, M LaFontaine, R Bok, M Van Criekinge, ... NeuroImage: Clinical 27, 102323, 2020 | 52 | 2020 |
| Interactive effects of molecular, therapeutic, and patient factors on outcome of diffuse low-grade glioma SL Hervey-Jumper, Y Zhang, JJ Phillips, RA Morshed, JS Young, ... Journal of Clinical Oncology 41 (11), 2029-2042, 2023 | 46 | 2023 |
| Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging J Cluceru, Y Interian, JJ Phillips, AM Molinaro, TL Luks, P Alcaide-Leon, ... Neuro-oncology 24 (4), 639-652, 2022 | 34 | 2022 |
| Comparison between short and long echo time magnetic resonance spectroscopic imaging at 3T and 7T for evaluating brain metabolites in patients with glioma Y Li, M Lafontaine, S Chang, SJ Nelson ACS chemical neuroscience 9 (1), 130-137, 2018 | 23 | 2018 |
| Assessment of higher-order singular value decomposition denoising methods on dynamic hyperpolarized [1-13C] pyruvate MRI data from patients with glioma S Vaziri, AW Autry, M Lafontaine, Y Kim, JW Gordon, HY Chen, JY Hu, ... NeuroImage: Clinical 36, 103155, 2022 | 15 | 2022 |
| Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed … AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, ... Cancer Cell 9, 157-73, 0 | 12 | |
| Tumor metabolism and neurocognition in CNS lymphoma H Geng, M Tsang, L Subbaraj, J Cleveland, L Chen, M Lu, J Sharma, ... Neuro-oncology 23 (10), 1668-1679, 2021 | 11 | 2021 |
| Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas AW Autry, M Lafontaine, L Jalbert, E Phillips, JJ Phillips, ... Journal of neuro-oncology 159 (1), 43-52, 2022 | 9 | 2022 |
| Simultaneous multi‐slice spin‐and gradient‐echo dynamic susceptibility‐contrast perfusion‐weighted MRI of gliomas M Han, B Yang, B Fernandez, M Lafontaine, P Alcaide‐Leon, A Jakary, ... NMR in Biomedicine 34 (1), e4399, 2021 | 8 | 2021 |
| Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas J Cluceru, SJ Nelson, Q Wen, JJ Phillips, A Shai, AM Molinaro, ... Neuro-oncology 22 (10), 1516-1526, 2020 | 8 | 2020 |
| Treatment-induced lesions in newly diagnosed glioblastoma patients undergoing chemoradiotherapy and heat-shock protein vaccine therapy P Alcaide-Leon, TL Luks, M Lafontaine, JM Lupo, H Okada, JL Clarke, ... Journal of Neuro-oncology 146, 71-78, 2020 | 6 | 2020 |
| Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective R Mathur, Q Wang, PG Schupp, A Nikolic, S Hilz, C Hong, NR Grishanina, ... Cell 187 (2), 446-463. e16, 2024 | 4 | 2024 |
| Automated prescription and reconstruction of brain MR spectroscopy data for rapid integration into the clinical workflow JC Crane, Y Li, MP Olson, M Lafontaine, S Maleschlijski, W Bian, ... Neurol Disord Epilepsy J 1 (1), 111, 2017 | 4 | 2017 |
| Multi-parametric hyperpolarized 13C/1H imaging reveals Warburg-related metabolic dysfunction and associated regional heterogeneity in high-grade human gliomas AW Autry, S Vaziri, M LaFontaine, JW Gordon, HY Chen, Y Kim, ... NeuroImage: Clinical 39, 103501, 2023 | 3 | 2023 |
| CBMT-36. INITIAL EXPERIENCE WITH HYPERPOLARIZED [2-13C]PYRUVATE MR IMAGING IN PATIENTS WITH IDH-MUTANT GLIOMA A Autry, B Chung, HY Chen, J Gordon, M Lafontaine, S Chang, ... Neuro-oncology 21 (Supplement_6), vi41-vi41, 2019 | 2 | 2019 |
| NIMG-44. INTEGRATING AUTOMATED LESION SEGMENTATIONS FROM SINGLE-IMAGES INTO ROUTINE CLINICAL WORKFLOW FOR VOLUMETRIC RESPONSE ASSESSMENT J Villanueva-Meyer, P Damasceno, M LaFontaine, J Hawkins, T Luks, ... Neuro-Oncology 22 (Suppl 2), ii157, 2020 | 1 | 2020 |
| NIMG-50. INITIAL EXPERIENCE: DETECTION OF ABERRANT HYPERPOLARIZED [1-13C]PYRUVATE METABOLISM IN PATIENTS WITH GBM PRIOR TO … A Autry, J Gordon, M LaFontaine, HY Chen, J Villanueva-Meyer, S Chang, ... Neuro-Oncology 22 (Supplement_2), ii159-ii159, 2020 | 1 | 2020 |
| Initial experience: detection of aberrant HP-13 C metabolism in patients with glioblastoma prior to resection A Autry, J Gordon, M LaFontaine, HY Chen, J Villanueva-Meyer, S Chang, ... ISMRM, 2020 | 1 | 2020 |
| Gene-47. A 3d atlas to evaluate the spatial patterning of genetic alterations and tumor cell states in glioma S Hilz, C Hong, L Jalbert, T Mazor, M Martin, A Kumar, S Shelton, K Wong, ... Neuro-oncology 21 (Supplement_6), vi107-vi108, 2019 | 1 | 2019 |
